Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration

O.L Gobbo, S.M O'Mara
  • Neuroscience, January 2004, Elsevier
  • DOI: 10.1016/j.neuroscience.2004.01.045

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Shane M O'Mara